+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Overactive Bladder Drug"

Overactive Bladder Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Overactive Bladder Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Overactive Bladder Treatment Market Report 2025 - Product Thumbnail Image

Overactive Bladder Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Overactive Bladder- Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 271 Pages
  • Global
From
Overactive Bladder Therapeutics Market 2025-2029 - Product Thumbnail Image

Overactive Bladder Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 221 Pages
  • Global
From
Overactive Bladder Treatment Market Report and Forecast 2025-2034 - Product Thumbnail Image

Overactive Bladder Treatment Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Overactive Bladder Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Overactive Bladder Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Solifenacin Succinate API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Solifenacin Succinate API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Genitourinary Drugs Global Market Report 2025 - Product Thumbnail Image

Genitourinary Drugs Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Darifenacin Hydrobromide Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Darifenacin Hydrobromide Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Nocturia Drugs - Global Strategic Business Report - Product Thumbnail Image

Nocturia Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 192 Pages
  • Global
From
Genito-Urinary Drugs: Market Share, and Growth Analysis by Product Type (Antibiotics, Antispasmodics, Hormonal Therapies), Application, End User, Technology - Product Thumbnail Image

Genito-Urinary Drugs: Market Share, and Growth Analysis by Product Type (Antibiotics, Antispasmodics, Hormonal Therapies), Application, End User, Technology

  • Report
  • August 2025
  • 150 Pages
  • Global
From
Oxybutynin Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Oxybutynin Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • March 2025
  • 109 Pages
  • Global
From
Urinary Incontinence Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Urinary Incontinence Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027 - Product Thumbnail Image

Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027

  • Report
  • July 2022
  • 203 Pages
  • Global
From
Overactive Bladder Treatment Market Size, Share & Trends Analysis Report, Type (Anticholinergics, Mirabegron, Neuromodulation, Botox), Disease Type (Idiopathic, Neurogenic), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Overactive Bladder Treatment Market Size, Share & Trends Analysis Report, Type (Anticholinergics, Mirabegron, Neuromodulation, Botox), Disease Type (Idiopathic, Neurogenic), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • December 2023
  • 100 Pages
  • Global
From
Genitourinary Drugs Market Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Genitourinary Drugs Market Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 110 Pages
  • Global
From
Overactive Bladder - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Overactive Bladder - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Overactive Bladder (OAB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Overactive Bladder (OAB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Genitourinary Drugs Market Report by Indication, Product, and Region 2024-2032 - Product Thumbnail Image

Genitourinary Drugs Market Report by Indication, Product, and Region 2024-2032

  • Report
  • August 2024
  • 142 Pages
  • Global
From
Loading Indicator

The Overactive Bladder Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat overactive bladder, a condition characterized by frequent urination, urgency, and incontinence. These drugs work by relaxing the bladder muscles, reducing the urge to urinate, and improving bladder control. Commonly used drugs include anticholinergics, beta-3 agonists, and muscarinic receptor antagonists. These drugs are available in both oral and topical formulations. The Overactive Bladder Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Astellas Pharma, Allergan, Merck, Sanofi, and GlaxoSmithKline. Show Less Read more